APRINOIA Therapeutics Co., Ltd.
Supporting treatment and brain health through next-generation diagnostic diagnostic and research on targeted therapies
Face to Face-to-face with various players
Through communication, the potential for business development will be expanded.
※For the convenience of each company, the number of logos posted is less than the number of tenants.
(Number of tenants: 69 as of September 1, 2024)